Metastatic Lesions

Hesham El Daly; Mariam Amer

doi:10.1017/9781316535042.017

Chapter 17 - Metastatic Lesions

Published online by Cambridge University Press: 12 November 2020

Attilio Orazi and

Hesham El Daly and

Jon van der Walt: Affiliation:
St Thomas’ Hospital, London
Attilio Orazi: Affiliation:
Texas Tech University
Daniel A. Arber: Affiliation:
University of Chicago

Book contents

Get access

Summary

The bone marrow (BM) is a frequent site of haematogenous spread for all types of cancer. Metastatic spread of disseminated tumour cells (DTCs) to the BM is detected in 0.2 to 12% of patients with solid tumours [1]. The variability in incidence is related to the incidence of the primary tumour and its homing behaviour [2]. Common primary tumours affecting the BM are listed below (Table 17.1).

Keywords

Metastatic pathogenesis syndromes DNA diagnosis biopsy scan niche

Type: Chapter
Information: Diagnostic Bone Marrow Haematopathology , pp. 298 - 313

DOI: https://doi.org/10.1017/9781316535042.017 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Filanovsky, K, Feldberg, E, Miller, EB. Predictive value of clinical and laboratory parameters for overt bone marrow metastasis in patients with solid malignancies. J Cancer Therapy. 2017;8(8), 773–84.CrossRef Google Scholar

Foucar, K, Richard, K, Czuchlewski, D. Bone Marrow Pathology. 3rd ed. Chicago, IL: ASCP; 2010: 657–659.Google Scholar

Munive, CO, Muro, MF, Ferreyros, G, et al. Outcome of breast cancer with symptomatic bone marrow involvement. J Clin Oncol. 2015;33,15 Suppl.Google Scholar

Joosse, SA, Gorges, TM, Pantel, K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol Med. 2014;7(1):1–11.Google Scholar

Alix-Panabières, C, Riethdorf, S, Pantel, K. Circulating tumor cells and bone marrow micrometastasis. Clin Cancer Res. 2008;14(16):5113–21.CrossRef Google Scholar PubMed

Cotta, CV, Konoplev, S, Medeiros, LJ, Bueso-Ramos, CE. Metastatic tumours in the bone marrow: histopathology and advances in the biology of the tumour cells and the bone marrow enviroment. Ann Diagn Pathol. 2006;10:169–92.CrossRef Google Scholar

Shiozawa, Y, Havens, AM, Pienta, KJ, Taichman, RS. The bone marrow niche: habitat to hematopoeitic and mesenchymal stem cells, and unwitting host to molecular parasites. Leukemia. 2008;22:941–50.Google Scholar

Bain, BJ, Clark, DM, Wilkins, BS. Bone Marrow Pathology, 4th edn. Wiley; 2011: 549–586.Google Scholar

Bain, BJ. Pathology of the bone marrow. In: Porwit, A, McCullough, J, Erber, WN. (Eds) Blood and Bone Marrow Pathology. Elsevier Ltd; 2011: 79–104.Google Scholar

Bedolla, G, Stemmerman, G. Pulmonary small cell carcinocythaemia. Lancet. 2003;361(9375):2193–66.Google Scholar

Bain, BJ. Blood Cells: A Practical Guide, 5th edn. Wiley-Blackwell; 2015.Google Scholar

Sailer, V, Schiffman, MH, Kossai, M, et al. Bone biopsy protocol for advanced prostate cancer in the era of precision medicine. Cancer. 2018;124(5):1008–15.Google Scholar

Proytcheva, M. Pediatric small blue cell tumors metastatic to the bone marrow. In Proytcheva, M (Ed.), Diagnostic Pediatric Hematopathology. Cambridge: Cambridge University Press; 2011: 379–394.Google Scholar

Alix-Panabier̀es, C, Pantel, K. Circulating tumor cells: liquid biopsy of cancer. Clin Chem. 2013;59(1):110–18.Google Scholar

Masuda, T, Hayashi, N, Iguchi, T, et al. Clinical and biological significance of circulating tumor cells in cancer. Molec Oncol. 2016;10(3):408–17.Google Scholar

Łukaszewski, B, Nazar, J, Goch, M, et al. Diagnostic methods for detection of bone metastases. Contemp Oncol. 2017;21(2):98–103.Google Scholar

Banys-Paluchowski, M, Krawczyk, N, Fehm, T. Potential role of circulating tumor cell detection and monitoring in breast cancer: a review of current evidence. Front Oncol. 2016;6.Google Scholar

Hegemann, M, Stenzl, A, Bedke, J, et al. Liquid biopsy: ready to guide therapy in advanced prostate cancer? BJU Int. 2016;118(6):855–63.Google Scholar

Page, K, Guttery, DS, Fernandez-Garcia, D, et al. Next generation sequencing of circulating cell-free DNA for evaluating mutations and gene amplification in metastatic breast cancer. Clin Chem. 2017;63(2):532–41.Google Scholar

Oellerich, M, Schütz, E, Beck, J, et al. Using circulating cell-free DNA to monitor personalized cancer therapy. Crit Rev Clin Lab Sci. 2017;54(3):205–18.Google Scholar

Hartkopf, AD, Wallwiener, M, Fehm, TN, et al. Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse. Ann Oncol. 2015;26(6):1155–60.Google Scholar

Zhou, L, Dicker, DT, Matthew, E, El-Deiry, WS, Alpaugh, RK. Circulating tumor cells: silent predictors of metastasis. F1000Res. 2017;6:ii.Google Scholar